119 related articles for article (PubMed ID: 20307026)
61. Prostate cancer.
Scott E
ScientificWorldJournal; 2011 Apr; 11():749-50. PubMed ID: 21479346
[TBL] [Abstract][Full Text] [Related]
62. Sorting out what makes sense in diagnosing, treating prostate cancer.
Beagin N
Am J Manag Care; 2014 Feb; 20(2 Spec No.):E5. PubMed ID: 25618382
[No Abstract] [Full Text] [Related]
63. The prevention of prostate cancer.
Griffiths K; Prezioso D; Turkes A; Denis LJ
Recent Results Cancer Res; 2007; 175():33-63. PubMed ID: 17432553
[TBL] [Abstract][Full Text] [Related]
64. Precision medicine path for prostate cancer.
Cancer Discov; 2015 Aug; 5(8):786. PubMed ID: 26080836
[TBL] [Abstract][Full Text] [Related]
65. Re: Ten-Year Mortality, Disease Progression, and Treatment-Related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.
Taneja SS
J Urol; 2020 May; 203(5):882-883. PubMed ID: 32073978
[No Abstract] [Full Text] [Related]
66. Re: Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial.
Taneja SS
J Urol; 2013 Jan; 189(1):124-5. PubMed ID: 23235214
[No Abstract] [Full Text] [Related]
67. [Review of hot topics in the diagnosis and treatment of prostate cancer in 2016].
Li HZ; Zhang YS
Zhonghua Wai Ke Za Zhi; 2017 Jan; 55(1):59-62. PubMed ID: 28056257
[TBL] [Abstract][Full Text] [Related]
68. [Prostate cancer: are we able to diagnose those in need? And are those that are diagnosed and treated those that are effectively in need?].
Palma dos Reis J
Acta Med Port; 2014; 27(1):12-4. PubMed ID: 24581188
[No Abstract] [Full Text] [Related]
69. Word of wisdom. Re: mortality results from the Göteborg randomised population-based prostate-cancer screening trial.
Hamdy FC
Eur Urol; 2010 Dec; 58(6):940-1. PubMed ID: 21414865
[No Abstract] [Full Text] [Related]
70. Words of wisdom. Re: mortality results from the Göteborg randomised population-based prostate-cancer screening trial.
Wirth MP; Froehner M
Eur Urol; 2010 Dec; 58(6):939-40. PubMed ID: 21414864
[No Abstract] [Full Text] [Related]
71. Words of wisdom. Re: mortality results from the Göteborg randomised population-based prostate-cancer screening trial.
Maroni P; Theodorescu D
Eur Urol; 2010 Dec; 58(6):938-9. PubMed ID: 21414863
[No Abstract] [Full Text] [Related]
72. Words of wisdom. Re: Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.
Ito K
Eur Urol; 2011 Apr; 59(4):659-61. PubMed ID: 21414887
[No Abstract] [Full Text] [Related]
73. Annual screening for prostate cancer did not reduce mortality from prostate cancer.
Canfield SE
Evid Based Med; 2009 Aug; 14(4):104-5. PubMed ID: 19648420
[No Abstract] [Full Text] [Related]
74. Erratum to 'Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received' [European Urology 77 (2020) 320-330].
Neal DE; Metcalfe C; Donovan JL; Lane JA; Davis M; Young GJ; Dutton SJ; Walsh EI; Martin RM; Peters TJ; Turner EL; Mason M; Bryant R; Bollina P; Catto J; Doherty A; Gillatt D; Gnanapragasam V; Holding P; Hughes O; Kockelbergh R; Kynaston H; Oxley J; Paul A; Paez E; Rosario DJ; Rowe E; Staffurth J; Altman DG; Hamdy FC;
Eur Urol; 2020 Sep; 78(3):e139-e143. PubMed ID: 32624282
[No Abstract] [Full Text] [Related]
75. Reducing Prostate Cancer Overdiagnosis.
Gulati R
N Engl J Med; 2022 Dec; 387(23):2187-2188. PubMed ID: 36477037
[No Abstract] [Full Text] [Related]
76. Recent advances in the diagnosis and management of prostate cancer.
BJU Int; 2021 May; 127(5):518-519. PubMed ID: 33913247
[No Abstract] [Full Text] [Related]
77. Advances in the diagnosis and treatment of prostate cancer.
Kirby R
Practitioner; 2010 Feb; 254(1726):21, 23-4, 2. PubMed ID: 20307026
[TBL] [Abstract][Full Text] [Related]
78. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
79. [Adenocarcinoma of the prostate].
Dvorácek J
Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
[TBL] [Abstract][Full Text] [Related]
80. Diagnosis, management and screening of early localised prostate cancer.
Selley S; Donovan J; Faulkner A; Coast J; Gillatt D
Health Technol Assess; 1997; 1(2):i, 1-96. PubMed ID: 9414541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
